Jazz Pharma inks deal with Saniona to develop SAN2355

Ireland-headquartered Jazz Pharmaceuticals (Nasdaq JAZZ) and Denmark’s Saniona (Nasdaq OMX: SANION) have entered into a global license agreement for Jazz to obtain exclusive worldwide rights to develop SAN2355, a highly differentiated, subtype-selective Kv7.2/Kv7.3 activator.

Saniona’s shares leapt as much as 58% to 12.92 kroner on the news of the potentially over billion-dollar deal.

The compound is in pre-clinical development for epilepsy and other potential indications, designed to overcome the limitations of non-selective Kv7-targeting compounds. Jazz will lead and fund further development, regulatory submissions, and global commercialization activities.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week.

Related Posts

Green or red dot? Your soap, shampoo and toothpaste will now reveal if they’re veg or non-veg

Green dot or red dot? Soaps, shampoos and toothpaste to reveal if they are veg or non-veg That green dot you usually look for on a food packet could soon…

Counterfeit rabies vaccine worth ₹2 lakh seized in Delhi

The Drugs Control Department has seized counterfeit rabies vaccine worth about ₹2 lakh from a firm in Chandni Chowk’s Bhagirath Palace, the Delhi government said on Tuesday. Health Minister Pankaj…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Green or red dot? Your soap, shampoo and toothpaste will now reveal if they’re veg or non-veg

Green or red dot? Your soap, shampoo and toothpaste will now reveal if they’re veg or non-veg

Counterfeit rabies vaccine worth ₹2 lakh seized in Delhi

Counterfeit rabies vaccine worth ₹2 lakh seized in Delhi

AIIA organises public awareness rally on 11th Ayurveda Day

AIIA organises public awareness rally on 11th Ayurveda Day

UKHSA and University of Oxford scientists uncover genetic changes in the bacteria causing severe Kent meningococcal disease outbreak

UKHSA and University of Oxford scientists uncover genetic changes in the bacteria causing severe Kent meningococcal disease outbreak

‘Broad daylight dacoity’, says Supreme Court on overpricing of essential cancer drugs

‘Broad daylight dacoity’, says Supreme Court on overpricing of essential cancer drugs

CDSCO finds one spurious drug sample in Delhi, 220 NSQs in Aug surveillance

CDSCO finds one spurious drug sample in Delhi, 220 NSQs in Aug surveillance